P. I. Tarr, Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection, Clin Infect Dis, vol.20, issue.1, p.7727633, 1995.

E. A. Rahal, S. M. Fadlallah, F. J. Nassar, N. Kazzi, and G. M. Matar, Approaches to treatment of emerging shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype, Fron Cell Infect Microbiol, vol.5, p.25853096, 2015.

J. Hu and A. G. Torres, Enteropathogenic Escherichia coli: foe or innocent bystander?, Clin Microbiol Infect, 2015.

S. Ansari, H. P. Nepal, R. Gautam, S. Shrestha, P. Neopane et al., Community acquired multidrug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal, Antimicrob Resist Infect Control, vol.4, p.15, 2015.

X. Wittebole, S. De-roock, and S. M. Opal, A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens, Virulence, vol.4, issue.1, pp.1-10, 2014.

T. M. Viertel, K. Ritter, and H. P. Horz, Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens, J Antimicrob Chemother, vol.69, issue.9, p.24872344, 2014.

L. Endersen, J. O'mahoney, C. Hill, R. P. Ross, O. Mcauliffe et al., Phage therapy in the food industry, Annu Rev Food Sci Technol, vol.5, issue.1, pp.327-376, 2014.

T. K. Lu and M. S. Koeris, The next generation of bacteriophage therapy, Curr Opin Microbiol, vol.14, issue.5, pp.524-555, 2011.

S. B. Cha, A. N. Yoo, W. J. Lee, M. K. Shin, M. H. Jung et al., Effect of bacteriophage in enterotoxigenic Escherichia coli (ETEC) infected pigs, J Vet Med Sci, vol.74, issue.8, p.22446401, 2012.

D. Maura, M. Galtier, L. Bouguenec, C. Debarbieux, and L. , Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine, Antimicrob Agents Chemother, vol.56, issue.12, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01538999

S. A. Sarker, S. Mccallin, C. Barretto, B. Berger, A. C. Pittet et al., Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh, Virology, vol.434, issue.2, pp.222-254, 2012.

A. Bruttin and H. Brussow, Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy, Antimicrob Agents Chemother, vol.49, issue.7, p.15980363, 2005.

S. Cusack and P. W. O'toole, Challenges and implications for biomedical research and intervention studies in older populations: Insights from the ELDERMET study, Gerontology, vol.59, issue.2, p.23146954, 2013.

M. J. Claesson, I. B. Jeffery, S. Conde, S. E. Power, E. M. O'connor et al., Gut microbiota composition correlates with diet and health in the elderly, Nature, vol.488, issue.7410, pp.178-84, 2012.

J. Murphy, B. Royer, J. Mahony, L. Hoyles, K. Heller et al., Biodiversity of lactococcal bacteriophages isolated from 3 Gouda-type cheese-producing plants, Journal of dairy science, vol.96, issue.8, pp.4945-57, 2013.

R. R. Chaudhuri, M. Sebaihia, J. L. Hobman, M. A. Webber, D. L. Leyton et al., Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042, PLoS One, vol.5, issue.1, p.8801, 2010.

A. Iguchi, N. R. Thomson, Y. Ogura, D. Saunders, T. Ooka et al., Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69, J Bacteriol, vol.191, issue.1, pp.347-54, 2009.

T. Hayashi, K. Makino, M. Ohnishi, K. Kurokawa, K. Ishii et al., Complete genome sequence of enterohemorrhagic Eschelichia coli O157:H7 and genomic comparison with a laboratory strain K-12, DNA Res, vol.8, issue.1, pp.11-22, 2001.

L. C. Crossman, R. R. Chaudhuri, S. A. Beatson, T. J. Wells, M. Desvaux et al., A commensal gone bad: complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407, J Bacteriol, vol.192, issue.21, pp.5822-5853, 2010.

S. Subramanian, J. M. Rhodes, C. A. Hart, B. Tam, C. L. Roberts et al., Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine, Inflamm Bowel Dis, vol.14, issue.2, p.17941093, 2008.

J. Hejnova, U. Dobrindt, R. Nemcova, C. Rusniok, A. Bomba et al., Characterization of the flexible genome complement of the commensal Escherichia coli strain A0 34/86 (O83: K24: H31). Microbiol, vol.151, pp.385-98, 2005.

M. A. Mulvey, J. D. Schilling, and S. J. Hultgren, Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection, Infect Immun, vol.69, issue.7, pp.4572-4581, 2001.

H. L. Mobley, D. M. Green, A. L. Trifillis, D. E. Johnson, G. R. Chippendale et al., Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains, Infect Immun, vol.58, issue.5, p.2182540, 1990.

S. O'flaherty, A. Coffey, W. Meaney, G. F. Fitzgerald, and R. P. Ross, The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus, J Bacteriol, vol.187, issue.20, pp.7161-7165, 2005.

E. Casey, J. Mahony, H. Neve, J. P. Noben, D. Bello et al., Novel phage group infecting Lactobacillus delbrueckii subsp. lactis, as revealed by genomic and proteomic analysis of bacteriophage Ldl1, Appl Environ Microbiol, vol.81, issue.4, pp.1319-1345, 2015.

M. M. Tunney, G. Ramage, T. R. Field, T. F. Moriarty, and D. G. Storey, Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa, Antimicrob Agents Chemother, vol.48, issue.5, p.15105149, 2004.

D. Field, N. Gaudin, F. Lyons, P. M. O'connor, P. D. Cotter et al., A bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermedius, PLoS One, vol.10, issue.3, p.119684, 2015.

F. Baron, M. Cochet, W. Ablain, N. Grosset, M. Madec et al., Rapid and cost-effective method for micro-organism enumeration based on miniaturization of the conventional plate-counting technique, Lait, vol.86, issue.3, pp.251-258, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00895582

L. Hoyles, A. L. Mccartney, H. Neve, G. R. Gibson, J. D. Sanderson et al., Characterization of virus-like particles associated with the human faecal and caecal microbiota, Res Microbiol, vol.165, issue.10, p.25463385, 2014.

A. L. Delcher, D. Harmon, S. Kasif, O. White, and S. L. Salzberg, Improved microbial gene identification with GLIMMER, Nucleic Acids Res, vol.27, issue.23, p.10556321, 1999.

S. F. Altschul, T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang et al., Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Res, vol.25, issue.17, p.9254694, 1997.

R. Overbeek, R. Olson, G. D. Pusch, G. J. Olsen, J. J. Davis et al., The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST), Nucleic Acids Res, vol.42, pp.206-220, 2014.

D. Laslett and B. Canback, ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences, Nucleic Acids Res, vol.32, issue.1, pp.11-17, 2004.

N. F. Alikhan, N. K. Petty, B. Zakour, N. L. Beatson, and S. A. , BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons, BMC Genomics, vol.12, p.402, 2011.

M. Dalmasso, C. Hill, and R. P. Ross, Exploiting gut bacteriophages for human health, Trends Microbiol, vol.22, issue.7, pp.399-405, 2014.

I. B. Jeffery, D. B. Lynch, O. 'toole, and P. W. , Composition and temporal stability of the gut microbiota in older persons, ISME J, vol.10, issue.1, pp.170-82, 2016.

M. L. Yap and M. G. Rossmann, Structure and function of bacteriophage T4, Future Microbiol, vol.9, issue.12, pp.1319-1356, 2014.

L. Truncaite, E. Simoliunas, A. Zajanckauskaite, L. Kaliniene, R. Mankeviciute et al., Bacteriophage vB_EcoM_FV3: a new member of "rV5-like viruses, Arch Virol, vol.157, issue.12, pp.2431-2436, 2012.

A. M. Kropinski, T. Waddell, J. Meng, K. Franklin, H. W. Ackermann et al., The host-range, genomics and proteomics of Escherichia coli O157:H7 bacteriophage rV5, Virol J, vol.10, p.76, 2013.

M. Kim and S. Ryu, Characterization of a T5-like coliphage, SPC35, and differential development of resistance to SPC35 in Salmonella enterica serovar typhimurium and Escherichia coli, Appl Environ Microbiol, vol.77, issue.6, pp.2042-50, 2011.

J. Mahony, O. Mcauliffe, R. P. Ross, and D. Van-sinderen, Bacteriophages as biocontrol agents of food pathogens, Curr Opin Biotechnol, vol.22, issue.2, pp.157-63, 2011.

N. Dufour, L. Debarbieux, M. Fromentin, and J. D. Ricard, Treatment of highly virulent extraintestinal pathogenic Escherichia coli pneumonia with bacteriophages, Crit Care Med, vol.43, issue.6, p.25803649, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01539037

R. Rahmani, G. Zarrini, F. Sheikhzadeh, and N. Aghamohammadzadeh, Effective phages as green antimicrobial agents against antibiotic-resistant hospital Escherichia coli, Jundishapur J Microbiol, vol.8, issue.2, p.17744, 2015.

K. E. Holt, S. Baker, F. X. Weill, E. C. Holmes, A. Kitchen et al., Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe, Nat Genet, vol.44, issue.9, pp.1056-1065, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01117702

H. W. Chang and K. H. Kim, Comparative genomic analysis of bacteriophage EP23 infecting Shigella sonnei and Escherichia coli, J Microbiol, vol.49, issue.6, pp.927-961, 2011.

S. T. Abedon, Lysis from without, Bacteriophage, vol.1, issue.1, pp.46-55, 2011.

M. Khan-mirzaei and A. S. Nilsson, Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy, PLoS One, vol.10, issue.3, p.118557, 2015.

Z. Lu and F. Breidt, Escherichia coli O157:H7 bacteriophage Phi241 isolated from an industrial cucumber fermentation at high acidity and salinity, Front Microbiol, vol.6, p.67, 2015.

H. Brussow, What is needed for phage therapy to become a reality in Western medicine?, Virology, vol.434, issue.2, pp.138-180, 2012.

F. Tang, Y. Li, W. Zhang, and C. Lu, Complete genome sequence of T4-Like Escherichia coli bacteriophage HX01, J Virol, vol.86, issue.24, p.13871, 2012.

J. Tsonos, L. H. Oosterik, H. N. Tuntufye, J. Klumpp, P. Butaye et al., A cocktail of in vitro efficient phages is not a guarantee for in vivo therapeutic results against avian colibacillosis, Vet Microbiol, vol.171, issue.3-4, p.24269008, 2014.

H. Brüssow, Phage therapy: the Escherichia coli experience, Microbiol, vol.151, issue.7, pp.2133-2173, 2005.

E. Denou, A. Bruttin, C. Barretto, C. Ngom-bru, H. Brussow et al., T4 phages against Escherichia coli diarrhea: potential and problems, Virology, vol.388, issue.1, 2009.

G. F. Hatfull and R. W. Hendrix, Bacteriophages and their genomes, Curr Opin Virol, vol.1, issue.4, pp.298-303, 2011.

M. Kim and S. Ryu, Characterization of a T5-like coliphage, SPC35, and differential development of resistance to SPC35 in Salmonella enterica serovar Typhimurium and Escherichia coli, Appl Environ Microbiol, vol.77, issue.6, pp.2042-50, 2011.

S. Parasion, M. Kwiatek, R. Gryko, L. Mizak, and A. Malm, Bacteriophages as an alternative strategy for fighting biofilm development, Polish J Microbiol, vol.63, issue.2, p.25115107, 2014.

G. O'flynn, R. P. Ross, G. F. Fitzgerald, and A. Coffey, Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7, Appl Environ Microbiol, vol.70, issue.6, p.15184139, 2004.

M. H. Ly-chatain, The factors affecting effectiveness of treatment in phages therapy, Front Microbiol, vol.5, p.51, 2014.

L. B. Coulter, R. J. Mclean, R. E. Rohde, and G. M. Aron, Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms, Viruses, vol.6, issue.10, pp.3778-86, 2014.

A. M. Comeau, F. Tétart, S. N. Trojet, M. Prère, and H. M. Krisch, Phage-Antibiotic Synergy (PAS): ?-Lactam and quinolone antibiotics stimulate virulent phage growth, PLoS One, vol.2, issue.8, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00180524

F. Kamal and J. J. Dennis, Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity, Appl Environ Microbiol, vol.81, issue.3, pp.1132-1140, 2015.